スポンサーサイト

上記の広告は1ヶ月以上更新のないブログに表示されています。
新しい記事を書く事で広告が消せます。


Cancer Topics Index 05/04/2016(Daily Test version/ 日刊テスト版)No.23

konpas.jpg
Cancer Topics Index 05/04/2016(Daily Test version/ 日刊テスト版) No.23

Flags 【海外:overseas】
◇NIH (National Institutes of Health)◇
capsule2-guide-for-parents-img.jpg
【小児がん/親のためのガイド】
Children with Cancer: A Guide for Parents (May 2016 NIH News in Health)
ダウンロードサイト (84ページのブックレットです)pdf_dl.png

【家族のための小児の緩和ケア/ナビゲーション】
NIH resources to help families navigate pediatric palliative care (May 3, 2016 NIH News Release)
Palliative Care: Conversations (website)

【ニューイングランド/井戸水中のヒ素による膀胱がんリスクの上昇】
Elevated bladder cancer risk in New England and arsenic in drinking water from private wells (May 2, 2016 NIH News Release)

logo-clinicaltrials-gov.png
rinnsyo1.jpg
※2週間前の情報を基準として掲載。一部の記事(がんと直接関連しないもの)は割愛しています。
20 studies found for: cancer | received from 04/20/2016 to 04/20/2016

【乳がん】
1 Recruiting
Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition: HR+ HER2- Postmenopausal Advanced Breast Cancer
Interventions: Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant; Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
Sponsor:Novartis Pharmaceuticals
ClinicalTrials.gov Identifier:NCT02753686

【大腸がん】
2 Recruiting
Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
Condition: Colorectal Neoplasms
Interventions: Drug: Two Anti-angiogenesis Drugs(Endostar and Thalidomide); Drug: Pure chemotherapy(Xelox)
Sponsor:The First People's Hospital of Hefei
ClinicalTrials.gov Identifier:NCT02748772

【乳がん】
3 Recruiting
Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: 68Ga-NOTA-BBN-RGD
Sponsor:Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:NCT02749019

【子宮頸がん】
4 Not yet recruiting
Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner
Conditions: Malignant Tumor of Cervix; Cervical Intraepithelial Neoplasia
Intervention: Device: Vaginal self-sampling brush
Sponsor:University Hospital, Lille
ClinicalTrials.gov Identifier:NCT02749110

【膀胱がん】
5 Active, not recruiting
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
Condition: Bladder Cancer
Intervention:
Sponsor:Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:NCT02756637

【下垂体腫瘍】
6 Not yet recruiting
Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Conditions: Pituitary Tumor; ACTH-producing Pituitary Tumour
Intervention: Drug: Pasireotide LAR
Sponsor:Columbia University
ClinicalTrials.gov Identifier:NCT02749227

【乳がん】
7 Completed
A Study of Trastuzumab (Herceptin) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Capecitabine; Drug: Docetaxel; Drug: Trastuzumab
Sponsor:Hoffmann-La Roche
ClinicalTrials.gov Identifier:NCT02748213

【がん】
8 Not yet recruiting
Imaging NSCLC Treatment Response to Immunotherapy
Condition: Cancer
Interventions: Other: Imaging - DW-MRI; Radiation: FDG PET-CT
Sponsor:Institute of Cancer Research, United Kingdom
ClinicalTrials.gov Identifier:NCT02753569

【卵巣がん/認知障害】
9 Recruiting
Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian Cancer
Conditions: Cognition Disorders; Polyneuropathies
Intervention: Drug: paclitaxel/ carboplatin chemotherapy
Sponsor:Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:NCT02753036

【がん】
10 Not yet recruiting
A Study to Assess Safety, Tolerability and Preliminary Activity of the Combination of FAK (Defactinib) and PD-1(Pembrolizumab) Inhibition in Patients With Advanced Solid Malignancies
Conditions: Carcinoma, Non-small-cell Lung; Mesothelioma; Pancreatic Neoplasms
Interventions: Drug: Defactinib; Drug: Pembrolizumab
Sponsor:NHS Greater Glasgow and Clyde
ClinicalTrials.gov Identifier:NCT02758587

【脳転移】
11 Recruiting
Whole Brain Radiation Using IMRT for Patients With Brain Metastases
Conditions: Neoplasm Metastasis; Central Nervous System Metastases
Intervention: Radiation: Intensity Modulated Radiotherapy
Sponsor:New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:NCT02753790

【口腔扁平上皮がん】
12 Recruiting
Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study
Conditions: Oral Squamous Cell Carcinoma; Carcinoma of Buccal Mucosa; Tongue Cancers; Head and Neck Cancers
Interventions: Drug: Celecoxib; Drug: Erlotinib; Drug: Celecoxib + Erlotinib
Sponsor:Tata Memorial Hospital
ClinicalTrials.gov Identifier:NCT02748707

【膵がん】
13 Recruiting
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine; Radiation: TS-1 with radiation
Sponsor:Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:NCT02754180

【膵がん】
14 Not yet recruiting
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer
Condition: Pancreatic Adenocarcinoma
Intervention: Drug: Preoperative modified FOLFIRINOX and postoperative gemcitabine
Sponsor:Asan Medical Center
ClinicalTrials.gov Identifier:NCT02749136

【下垂体腺腫/記憶障害】
15 Not yet recruiting
Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory
Conditions: Cavernous Sinus Meningioma; Pituitary Adenoma
Intervention: Other: Evaluation of autobiographical memory
Sponsor:University Hospital, Bordeaux
ClinicalTrials.gov Identifier:NCT02750371

【多発性骨髄腫】
16 Not yet recruiting
A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
Condition: Relapsed/Refractory Multiple Myeloma
Interventions: Drug: Venetoclax; Drug: Placebo; Drug: Bortezomib; Drug: Dexamethasone
Sponsor:AbbVie
ClinicalTrials.gov Identifier:NCT02755597

【びまん性大細胞型B細胞性リンパ腫】
17 Not yet recruiting
Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
Conditions: Diffuse Large B Cell Lymphoma; Primary Mediastinal (Thymic) Large B-cell Lymphoma; Transformed Indolent Lymphoma; Recurrent Disease; Refractory Cancer
Intervention: Drug: Bendamustine 90 mg/m2 IV on Days 1-2, Cycles 1-6
Sponsor:Meirav Kedmi MD
ClinicalTrials.gov Identifier:NCT02747732

【膀胱がん/疼痛】
18 Active, not recruiting
Persistent Pain After Cystectomy for Bladder Cancer
Conditions: Pain; Surgery; Post Operative Pain
Intervention:
Sponsor:Washington University School of Medicine
ClinicalTrials.gov Identifier:NCT02751346

【扁平上皮がん/基底細胞がん】
20 Not yet recruiting
Intraoperative Margin Assessment During Mohs Surgery
Conditions: Squamous Cell Carcinoma (SCC); Basal Cell Carcinoma (BCC)
Intervention: Device: Multimodal Spectroscopy (MMS)
Sponsor:Seton Healthcare Family
ClinicalTrials.gov Identifier:NCT02750033

【びまん性大細胞型B細胞リンパ腫】
22 Recruiting
Reduced Chemotherapy in Low Risk DLBCL
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: Rituximab; Drug: Cyclophosphamide; Drug: Epirubicin; Drug: Vincristine; Drug: Prednisone
Sponsor:Ruijin Hospital
ClinicalTrials.gov Identifier:NCT02752815

animated-european-union-flag.gif
◇EU, EMA, CHMP, Cancer Research UK, NICE◇
cell-breast-cancer.jpg
【乳がん/個別化医療】
DNA analysis brings scientists step closer to ‘complete picture’ of breast cancer (3 May 2016 News report:In collaboration with the Press Association)
An analysis of the complete genetic code of hundreds of breast tumours could lead to more personalised care for patients, according to an international team of scientists.The results reveal that patients’ tumours may be highly individual. And experts have said that the new findings offer a more comprehensive view of breast cancer.

<Medical Journal & Other News>
headline.jpg
【コレステロール代謝と膵がんコントロール】JOURNAL:Oncogene
Research points to a new treatment for pancreatic cancer (05/03/2016 EurekAlert!/PURDUE UNIVERSITY)
WEST LAFAYETTE, Ind. -- Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis, pointing to a potential new treatment using drugs previously developed for atherosclerosis."We show for the first time that if you control the cholesterol metabolism you could reduce pancreatic cancer spread to other organs," said Ji-Xin Cheng, a professor in Purdue University's Weldon School of Biomedical Engineering and Department of Chemistry. "We chose pancreatic cancer to test this approach because it is the most aggressive disease of all the cancers."

【卵巣除去による大腸がんリスクの上昇】JOURNAL:British Journal of Surgery
Ovary removal may increase the risk of colorectal cancer (05/04/2016 EurekAlert!/WILEY)
Colorectal cancer may rise in women who have their ovaries removed, according to new research.The development of colorectal cancer is influenced by hormonal factors, and removal of the ovaries alters a woman's sex hormone levels. Among 195,973 Swedish women who had undergone ovary removal between 1965 and 2011, there was a 30% increase in the rate of colorectal cancer compared with the general population. After accounting for various factors, women who had both ovaries removed had a 2.3-times higher risk of rectal cancer than those who had only one ovary removed.

Graphics 【日本国内:Japan】
<News>
【乳がん】
【がん電話相談から】ルミナールA型乳がん全摘術後抗がん剤治療は? (05/03/2016 産経ニュース)

【乳がん】
乳がん専門医 「告知されたら思い切り悲しんでよい」濱岡ブレストクリニック・濱岡剛院長 (05/03/2016 NEWSポストセブン)

【乳がん】
乳がん経験者の体験談 告知から6年で274万円かかった ファイナンシャルプランナー・黒田尚子さん(05/03/2016 NEWSポストセブン)

【虚偽】
中国当局が百度への調査を開始、同社の検索で得た情報でがん治療を受けた大学生の死亡を受けて―米メディア (05/03/2016 Record china)

【闘病記】
闘病記にはそれほど期待していないんです アピタル・高柳由香 (05/02/2016 朝日新聞デジタルapital)
関連記事


コメント
コメントの投稿


管理者にだけ表示を許可する

トラックバック
http://paxxmedia.blog38.fc2.com/tb.php/9118-0fd56cf7
この記事にトラックバックする(FC2ブログユーザー)


上記広告は1ヶ月以上更新のないブログに表示されています。新しい記事を書くことで広告を消せます。